Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Antipsychotic monotherapy (APM) is considered best-acceptable treatment option regardless of antipsychotic class and formulation types for treating schizophrenia. However, antipsychotic polypharmacy (APP) has been also widely utilized in routine clinical practice. Despite APP has some clinical benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316655/
https://www.ncbi.nlm.nih.gov/pubmed/34294613
http://dx.doi.org/10.9758/cpn.2021.19.3.434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316655/
https://www.ncbi.nlm.nih.gov/pubmed/34294613
http://dx.doi.org/10.9758/cpn.2021.19.3.434

Ejemplares similares